FIS vs TERN · P/E 7.9, rev $2.60B vs $6.12B cap
Fidelity National Information Services Inc (FIS) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Fidelity National Information Services Inc (FIS) is a information technology services company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported FIS revenue for 2024-12-31 was $2.60B. Net income was $282.0M. Revenue was up 1.1% from 2024-09-30 to 2024-12-31. FIS currently screens at market cap $21.12B and trailing P/E 7.9.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
FIS currently screens at market cap $21.12B and trailing P/E 7.9. TERN currently screens at market cap $6.12B.
Not investment advice. Open the FIS and TERN stock pages for the full models.
Not investment advice.